Researcher profile
Phillip Good
Affiliations
Organizations
Public evidence
8 connected articles
Medicinal cannabis for symptom control in advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of 1:1 tetrahydrocannabinol and cannabidiol.2025 · Europe PMCMedicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial.2024 · Europe PMCDefining research priorities and needs in cancer symptoms for adults diagnosed with cancer: an Australian/New Zealand modified Delphi study2023 · PubMed Central Open AccessExploring potential anti-inflammatory effects of medicinal cannabis.2023 · PubMed Central Open Access'What price do you put on your health?': Medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer.2022 · PubMed Central Open AccessUsing a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer.2022 · PubMed Central Open AccessAn Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care.2020 · Europe PMCOral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD).2019 · Europe PMC
Matched by exact identifiers only. Profile data: Corpus/OpenAlex.